Biora Therapeutics(BIORQ)
$0.00-0.00 (-99.00%)
BIORQ
Biora Therapeutics stock drug pipeline
$0.00
At close:-0.00 (-99.00%)
Want to see BIORQ full AI Analyst Report?
Biora Therapeutics (BIORQ) Drug Pipeline
1,085 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bt-600 | Healthy | Phase I | Completed | BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects | Feb 08, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bt-600 | Phase I | Healthy | Completed | BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects | Feb 08, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biora Therapeutics Inc. (BIORQ) have in its pipeline
Biora Therapeutics BIORQ is currently developing the following drugs: Bt-600. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

